The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
702
WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE
Date
May 8, 2023
Explore related products in the following collection:
The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease…
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease…
BACKGROUND: Gastroesophageal reflux disease (GERD), with or without hiatal hernia (HH), affects millions of individuals worldwide, with a significant economic impact and loss of health-related quality of life…